2022 - European Society for Clinical Microbiology and Infectious Diseases Excellence Award
His scientific interests lie mostly in Virology, Coronavirus, Virus, Middle East respiratory syndrome coronavirus and Antibody. His research in Virology intersects with topics in Serology and Antigen. His Coronavirus research integrates issues from Cell culture, Virus genetics, Human Virus, Severe acute respiratory syndrome coronavirus 2 and Coronaviridae.
In his work, Antibody response is strongly intertwined with Sequence analysis, which is a subfield of Virus. His Middle East respiratory syndrome coronavirus study combines topics in areas such as Veterinary medicine, Middle East respiratory syndrome, Genome and Lower respiratory tract infection. His Antibody research incorporates elements of Receptor and Betacoronavirus.
His primary areas of study are Virology, Virus, Immunology, Coronavirus and Middle East respiratory syndrome coronavirus. Bart L. Haagmans interconnects Antibody and Severe acute respiratory syndrome coronavirus 2 in the investigation of issues within Virology. His biological study spans a wide range of topics, including Cytokine, Immune system, Pathogenesis and Vaccination.
His Immunology research incorporates themes from Gastroenterology and Internal medicine. His work in Coronavirus addresses subjects such as Proteases, which are connected to disciplines such as Cell biology. His research integrates issues of Veterinary medicine, Receptor, Middle East respiratory syndrome and Respiratory tract in his study of Middle East respiratory syndrome coronavirus.
His primary areas of investigation include Virology, Coronavirus, Severe acute respiratory syndrome coronavirus 2, Antibody and Virus. His Virology research is multidisciplinary, incorporating elements of Middle East respiratory syndrome coronavirus, Monoclonal antibody and Betacoronavirus. His Coronavirus research is multidisciplinary, incorporating perspectives in Serine, Proteases, RNA, Public health and Seroprevalence.
His Severe acute respiratory syndrome coronavirus 2 research includes themes of In vitro, Pandemic, Spike Protein and Respiratory system. His studies in Antibody integrate themes in fields like Disease and Antigen. His Virus study also includes
Virology, Coronavirus, Antibody, Severe acute respiratory syndrome coronavirus 2 and Serology are his primary areas of study. His Virology study incorporates themes from Pandemic, Monoclonal antibody and Betacoronavirus. The concepts of his Coronavirus study are interwoven with issues in Viral evolution, Outbreak, Messenger RNA, Viral replication and Respiratory system.
Bart L. Haagmans has included themes like Middle East respiratory syndrome coronavirus and Antigen in his Antibody study. His study explores the link between Severe acute respiratory syndrome coronavirus 2 and topics such as Public health that cross with problems in Emergency Use Authorization and Data science. The various areas that Bart L. Haagmans examines in his Virus study include Odds ratio, Middle East respiratory syndrome and Infection control.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya;Susan C. Baker;Ralph S. Baric;Raoul J. de Groot.
Nature microbiology (2020)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.
Victor M. Corman;Olfert Landt;Marco Kaiser;Richard Molenkamp.
Eurosurveillance (2020)
Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group
Alexander E. Gorbalenya;Alexander E. Gorbalenya;Susan C. Baker;Ralph Baric;Raoul J. de Groot.
bioRxiv (2020)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj;Huihui Mou;Saskia L. Smits;Dick H. W. Dekkers.
Nature (2013)
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
Nisreen M.A. Okba;Marcel A. Müller;Wentao Li;Chunyan Wang.
Emerging Infectious Diseases (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection.
Chunyan Wang;Wentao Li;Dubravka Drabek;Nisreen M.A. Okba.
Nature Communications (2020)
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
Sander van Boheemen;Miranda de Graaf;Chris Lauber;Theo M. Bestebroer.
Mbio (2012)
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
Chantal B.E.M. Reusken;Bart L. Haagmans;Marcel A. Müller;Carlos Gutierrez.
Lancet Infectious Diseases (2013)
SARS-CoV-2 productively infects human gut enterocytes.
Mart M. Lamers;Joep Beumer;Jelte van der Vaart;Kèvin Knoops.
Science (2020)
Virology: SARS virus infection of cats and ferrets.
Byron E. E. Martina;Bart L. Haagmans;Thijs Kuiken;Ron A. M. Fouchier.
Nature (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Veterinary Medicine Hannover, Foundation
Erasmus University Rotterdam
Utrecht University
Erasmus University Rotterdam
Erasmus University Rotterdam
Utrecht University
Erasmus University Rotterdam
Charité - University Medicine Berlin
Autonomous University of Barcelona
Erasmus University Rotterdam
University of California, San Diego
Rutgers, The State University of New Jersey
Nanyang Technological University
Razi University
The University of Texas at Austin
University of Chicago
National Yang Ming Chiao Tung University
National Research Council (CNR)
University of Bristol
University of Nebraska–Lincoln
University of Tübingen
University of Wales Trinity Saint David
University of Wisconsin–Madison
University of Padua
University of Oxford
Peking University